EMEA Office
Louizalaan 489
1050 Brussels
Belgium
In a world saturated with AI narratives, Quality Outlook 2026 focuses on what actually determines success in life sciences: the people behind the systems.
It examines how QA leaders are evolving into data-literate, digitally fluent decision-makers — the human agents who interpret risk, guide technology, and protect trust as complexity accelerates.
The reality
AI is everywhere. Regulations are tightening. Data is exploding.
Yet life sciences organizations are still paying the price for reactive quality: delays, remediation costs, fractured systems, and eroded trust.
The question isn’t how fast we can automate quality — it’s how we do it without losing human judgment.
The reality check
The future of quality isn’t about AI replacing people.
It’s about QA leaders evolving into QA Agents: professionals who combine data, digital systems, and AI with context, ethics, and accountability.
They don’t just ensure compliance. They interpret risk, guide technology, and protect patients.
Based on insights from hundreds of quality professionals across life sciences, this report combines real-world data, expert perspectives, and practical guidance for QA leaders preparing for 2026.
1. Deloitte 2026 Life Sciences Outlook
2. The FDA Insider
3. Sedgwick, 2025 Recall Index
4. American Society for Quality (ASQ)
5. Scilife Quality Maturity Scan
EMEA Office
Louizalaan 489
1050 Brussels
Belgium
US Office
Scilife Inc.
228 E 45th St. RM 9E
New York, NY 10017
PRODUCT
INDUSTRIES
RESOURCES
COMPANY
Contact Us
EMEA Office
Louizalaan 489
1050 Brussels
Belgium
US Office
Scilife Inc.
228 E 45th St. RM 9E
New York, NY 10017
Copyright 2025 Scilife N.V. All rights reserved.